Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 754

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

Patard, Jean-Jacques, Leray, Emmanuelle, Rioux-Leclercq, Nathalie, Cindolo, Luca, Ficarra, Vincenzo, Zisman, Amnon, De La Taille, Alexandre, Tostain, Jacques, Artibani, Walter, Abbou, Claude C., Lobel, Bernard, Guillé, François, Chopin, Dominique K., Mulders, Peter F.A., Wood, Christopher G., Swanson, David A., Figlin, Robert A., Belldegrun, Arie S., Pantuck, Allan J.·2005·Journal of Clinical Oncology

Abstract

Purpose: To analyze to what extent histologic subtype is of prognostic importance in renal cell carcinoma based on a large, international, multicenter experience. Patients and Methods: Four thousand sixty-three patients from eight international centers were included in this retrospective study. Histologic subtype (1997 International Union Against Cancer [UICC] criteria of tumor response), age, sex, TNM stage, Fuhrman grade, tumor size, Eastern Cooperative Oncology Goup performance status (ECOG PS), and overall survival were determined in all cases. The prognostic values of clear cell, papillary, and chromophobe histologic features were assessed by uni- and multivariate analysis using the Kaplan-Meier method and Cox model, respectively. Results: Clear cell, papillary, and chromophobe carcinomas accounted for 3,564 (87.7%), 396 (9.7%) and 103 (2.5%) cases, respectively. In univariate analysis, a trend toward a better survival was observed when clear cell, papillary, and chromophobe histologies were considered prognostic categories (log-rank P = .0007). However, in multivariate analysis, TNM stage, Fuhrman grade and ECOG PS, but not histology, were retained as independent prognostic variables (P < .001). Conclusion: The stratification in three main renal cell carcinoma histologic subtypes as defined by the 1997 UICC–American Joint Committee on Cancer consensus should not be considered a major prognostic variable comparable to TNM stage, Fuhrman grade and ECOG PS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2005.07.055

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 754

Metadata

Authors
Patard, J.-J., Leray, E., Rioux-Leclercq, N., Cindolo, L., Ficarra, V., Zisman, A., De La Taille, A., Tostain, J., Artibani, W., Abbou, C. C., Lobel, B., Guillé, F., Chopin, D. K., Mulders, P. F. A., Wood, C. G., Swanson, D. A., Figlin, R. A., Belldegrun, A. S., & Pantuck, A. J.
Venue
Journal of Clinical Oncology
Published
2005-04-20
Volume
23
Issue
12
Pages
2763-2771
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2102900043
Cited by
754
References
16
FWCI
27.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience. https://app.cochat.ai/papers/10.1200/jco.2005.07.055
The paper
Patard, J.-J., Leray, E., Rioux-Leclercq, N., Cindolo, L., Ficarra, V., Zisman, A., De La Taille, A., Tostain, J., Artibani, W., Abbou, C. C., Lobel, B., Guillé, F., Chopin, D. K., Mulders, P. F. A., Wood, C. G., Swanson, D. A., Figlin, R. A., Belldegrun, A. S., & Pantuck, A. J. (2005). Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.07.055

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.